Back to search
Maternal Cytomegalovirus Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Maternal Cytomegalovirus Infections trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Maternal Cytomegalovirus Infections trials you may qualify forPatients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened. All pa…
Congenital cytomegalovirus (CMV) infection is the most common congenital infection with a birth prevalence of 0.4% in Europe. It is the leading non-genetic caus…
This study will evaluate whether a brief prenatal clinic-based cytomegalovirus (CMV) risk-reduction behavioral intervention will prevent maternal CMV infections…
A phase 3, open-label, single-arm, prospective, multi-center trial of Cytotect CP Biotest (BT097) for prevention of maternal-fetal CMV transmission after primar…
The goals of this observational study are: i) investigate the natural history of non-primary (i.e. reactivation and reinfection) HCMV infection in HCMV-seroposi…